Clinical Studies on Silybin Phytosome

Clinical Study – Ref20C15

A pilot study on the liver protective effect of silybinphosphatidylcholine complex (Silybin Phytosome) in chronic active hepatitis

G. Buzzelli, S1., Moscarella, A. 1, Giusti, A. 1, Duchini, C. 1, Marena and M. Lampertico 21

Instituto di Clinica Medica , Universita Degli Studi di Firenze, Firenze and 2Medical Department, Inverni Dell Beffa, Milan ItalySee National Library of Medicine

This was a 20 patient study. 10 patients were treated and 10 were given a placebo. Liver enzyme levels were reduced by 20-30% on average with just one week of usage.In conclusion, IdB 1016 (Silybin Phytosome) seems to improve the biochemical signs of hepatocellular necrosis and/or increases cellular permeability in patients affected by chronic active hepatitis.